ArticleDigital health
Diabetic retinopathy detection and grading system using deep learning approach.
Article in Digital health. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Early screening for diabetic retinopathy (DR) prevents vision loss in diabetic patients. Objective: To classify DR cases, this study suggests computer-assisted screening and diagnosis. The proposed methodology consists of retinal blood vessel, macular region, and exudate segmentation. In this study, exudates were screened, and DR was classified as mild, moderate, or severe by analyzing the presence of exudates in the macular region. Methods: The bit-plane morphological slicing technique was employed to segment the macular region. The U-Net deep learning approach was used to segment the exudates from the retinal images, and the proposed methodologies were applied and evaluated on retinal images in the publicly available Methods to Evaluate Segmentation and Indexing Techniques in the field of Retinal Ophthalmology (MESSIDOR) and High-Resolution Fundus (HRF) datasets. Finally, DR can be diagnosed by analyzing the presence of exudates in the macular region, and DR can be diagnosed as mild, moderate, or severe based on the severity levels. The conventional segmentation algorithms segment and locate the internal boundary of pixels in both exudates and macula. In contrast with the conventional segmentation methods, the proposed algorithm segments and locates both internal and external boundary of pixels in both exudates and macula region which increases the segmentation accuracy. Results: The proposed macular region segmentation method obtained 98.9% SeI, 99.2% SpI, and 99.1% AccI for the MESSIDOR dataset. The proposed macular region segmentation method obtained 99.2% SeI, 99.7% SpI, and 99.8% AccI for the HRF dataset. The proposed exudate segmentation method obtained 99.3% SeI, 99.2% SpI, and 99.2% AccI for the MESSIDOR dataset. The proposed exudate segmentation method obtained 99.7% SeI, 99.3% SpI, and 99.1% AccI for the HRF dataset. Conclusion: The segmentation time period of both exudates and macula region in retinal image is low when comparing with other segmentation methods. Moreover, this proposed segmentation and diagnosis method was tested with other DIARETDB1, Retinal Fundus Multi-disease Image, and Fundus Image Registration Dataset datasets to validate the effectiveness of the proposed method.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.